Danielle McDonnell Boyd
Head of Regulatory and Quality
Cala Health
Danielle McDonnell Boyd
Danielle joins Cala Health with over 13 years experience in Regulatory Affairs, Clinical Research, Quality Systems and project management for pre and post market stages of Class II and Class III medical devices and wearables.
Welcome to The Cala Health team, Danielle!
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. 
Learn more at www.calahealth.com